Log in to save to my catalogue

High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded t...

High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5508574

High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

About this item

Full title

High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

Publisher

New York: Nature Publishing Group US

Journal title

Nature biotechnology, 2016-04, Vol.34 (4), p.419-423

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

A method called PRISM rapidly identifies drug candidates that are effective against specific cancer cell lines.
Hundreds of genetically characterized cell lines are available for the discovery of genotype-specific cancer vulnerabilities. However, screening large numbers of compounds against large numbers of cell lines is currently impractical, a...

Alternative Titles

Full title

High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5508574

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5508574

Other Identifiers

ISSN

1087-0156

E-ISSN

1546-1696

DOI

10.1038/nbt.3460

How to access this item